These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4002663)

  • 21. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase.
    Jain M; Cui L; Brenner DA; Wang B; Handy DE; Leopold JA; Loscalzo J; Apstein CS; Liao R
    Circulation; 2004 Feb; 109(7):898-903. PubMed ID: 14757696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term exposure to Cu2+ and Cd2+ on the pentose phosphate pathway dehydrogenase activities in the ovary of adult Bufo arenarum: possible role as biomarker for Cu2+ toxicity.
    Carattino MD; Peralta S; Pérez-Coll C; Naab F; Burlón A; Kreiner AJ; Preller AF; de Schroeder TM
    Ecotoxicol Environ Saf; 2004 Mar; 57(3):311-8. PubMed ID: 15041254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New stable mutant (Gd(-) variants: G6PD Tashkent and G6PD Nucus. Molecular basis of hereditary enzyme deficiency.
    Yermakov N; Tokarev Ju; Chernjak N; Schönian G; Grieger M; Guckler A; Jacobasch G; Mahmudova M; Bahramov S
    Acta Biol Med Ger; 1981; 40(4-5):559-62. PubMed ID: 7315103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
    Gupte SA; Levine RJ; Gupte RS; Young ME; Lionetti V; Labinskyy V; Floyd BC; Ojaimi C; Bellomo M; Wolin MS; Recchia FA
    J Mol Cell Cardiol; 2006 Aug; 41(2):340-9. PubMed ID: 16828794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of prostaglandins F2 and F2 alpha on the pentosephosate pathway in human blood platelets].
    Makarov SA; Kudriavtseva GV; Kolotilova AI
    Vopr Med Khim; 1983; 29(5):27-32. PubMed ID: 6316661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte glucose 6 phosphate dehydrogenase (G6PD) as prognostic indicator in children with acute lymphocytic leukemia.
    Devi GS; Prasad MH; Reddy PP; Rao DN
    Indian J Exp Biol; 1995 Nov; 33(11):829-32. PubMed ID: 8786155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose 6-phosphate dehydrogenase: in vitro and in vivo effects of dantrolene sodium.
    Beydemir S; Gülçin I; Küfrevioğlu OI; Ciftçi M
    Pol J Pharmacol; 2003; 55(5):787-92. PubMed ID: 14704475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glucose-6-phosphate dehydrogenase activity evaluated in blood preserved at +4 degrees C in A.C.D. (Acetate, Citrate, Dextrose), in healthy subjects and in patients with Cooley's disease].
    Norelli MT; Agricola R; Ferrando T
    Minerva Pediatr; 1971 Nov; 23(44):1829-36. PubMed ID: 5163019
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucose-6-phosphate dehydrogenase activity in male premature and term neonates.
    Mesner O; Hammerman C; Goldschmidt D; Rudensky B; Bader D; Kaplan M
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F555-7. PubMed ID: 15499154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of some anesthetic drugs on enzymatic activity of human red blood cell glucose 6-phosphate dehydrogenase.
    Altikat S; Ciftçi M; Büyükokuroğlu ME
    Pol J Pharmacol; 2002; 54(1):67-71. PubMed ID: 12020046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of glucose-6-phosphate dehydrogenase levels in red cell preparations.
    Echler G
    Am J Med Technol; 1983 Apr; 49(4):259-62. PubMed ID: 6846390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [P1 A2: a new genetic risk factor for myocardial infarction].
    Bernát SI; Metz E; Gonda F; Torday A
    Orv Hetil; 1998 Sep; 139(39):2319-21. PubMed ID: 9789986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucose-6-phosphate dehydrogenase in the thrombocytes of patients with thrombopenia and thrombopathy].
    Schulz K; Dabels J
    Klin Wochenschr; 1968 Apr; 46(8):447-8. PubMed ID: 5686119
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of dietotherapy on thrombocyte lysosomal hydrolase activity in patients with hyperlipidemia and ischemic heart disease].
    Vasil'ev AV; Meshcheriakova VA; Pogozheva AV; Shimanovskaia NP; Samsonov MA
    Patol Fiziol Eksp Ter; 1987; (4):71-4. PubMed ID: 3684343
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombocyte lysosomal hydrolase activity in patients with ischemic heart disease, hyperlipidemia and obesity against a background of different diets].
    Vasil'ev AV; Shimanovskaia NP; Pogozheva AV; Samsonov MA; Tutel'ian VA
    Vopr Pitan; 1987; (6):14-7. PubMed ID: 3439081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of glucose-6-phosphate dehydrogenase in acute myocardial infarction and in controls.
    Singh A; Sharma A; Singh K
    Indian J Med Sci; 1982 Feb; 36(2):25-8. PubMed ID: 7141495
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determining glycogen levels in the thrombocytes of patients with ischemic heart disease].
    Gushchina LA; Uspenskaia VG; Lygina OA
    Lab Delo; 1986; (6):348-50. PubMed ID: 2427781
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glucose-6-phosphate dehydrogenase activity in rat serum in hyperoxia, hypoxia, and cooling].
    Goroshinskaia IA; Ananian AA; Bronovitskaia ZG; Shugaleĭ VS
    Vopr Med Khim; 1984; 30(1):60-4. PubMed ID: 6710939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adenase inhibitor in thrombocytes of healthy humans].
    Sokovnina IaM; Tentsova IA; Debov SS
    Vopr Med Khim; 1977; (3):425-7. PubMed ID: 888412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombocyte adenase of healthy monkeys and monkeys with different degrees of hemoblastosis].
    Sokovnina IaM; Debov SS; Iakovleva LA; Tskhakaia NA
    Biull Eksp Biol Med; 1977 Nov; 84(11):555-6. PubMed ID: 412528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.